Lead discovery using molecular docking

Current Opinion in Chemical Biology

Volumn 6, Issue 4, 2002, Pages 439-446

  Shoichet, Brian K ^a   McGovern, Susan L ^a   Wei, Binqing ^a   Irwin, John J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; LIGAND; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR;

ALGORITHM; DRUG MANUFACTURE; DRUG TARGETING; ENZYME STRUCTURE; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; X RAY ANALYSIS;

EID: 0036680148     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00339-3     Document Type: Review

References (59)

1. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B
2. Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis
3. Subnanomolar inhibitors from computer screening: A model study using human carbonic anhydrase II
4. Structure-based generation of a new class of potent Cdk4 inhibitors: New de novo design strategy and library design
5. A new target for shigellosis: Rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase
6. Predicting the structures of protein complexes: A step in the right direction
7. Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase
8. In silico discovery of novel retinoic acid receptor agonist structures
9. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening
10. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis
11. Discovery of a novel serine protease inhibitor utilizing a structure- based and experimental selection of fragments technique
12. PRO_SELECT: Combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors
13. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
14. Combinatorial computational method gives new picomolar ligands for a known enzyme
15. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore
16. Use of MCSS to design small targeted libraries: Application to picornavirus ligands
17. Library design and virtual screening using multiple 4-point pharmacophore fingerprints
18. A fast algorithm for searching for molecules containing a pharmacophore in very large virtual combinatorial libraries
19. Virtual screening of combinatorial libraries across a gene family: In search of inhibitors of Giardia lamblia guanine phosphoribosyltransferase
20. Design, docking, and evaluation of multiple libraries against multiple targets
21. Virtual screening - An overview
22. High-throughput docking for lead generation
23. EUDOC: A computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases
24. Efficient electrostatic solvation model for protein-fragment docking
25. Ligand-receptor docking with the Mining Minima optimizer
26. Accommodating protein flexibility in computational drug design
27. FlexE: Efficient molecular docking considering protein structure variations
28. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock
29. Molecular docking to ensembles of protein structures
30. Virtual screening with solvation and ligand-induced complementarity
31. Solvation energy density occlusion approximation for evaluation of desolvation penalties in biomolecular interactions
32. Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method
33. Analysis of knowledge-based protein-ligand potentials using a self-consistent method
34. Modifications of the scoring function in FlexX for virtual screening applications
35. Knowledge-based scoring function to predict protein-ligand interactions
36. Effect of ligand volume correction on PMF scoring
37. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins
38. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations
39. Evaluation of docking functions for protein-ligand docking
40. Consensus scoring for ligand/protein interactions
41. A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities
42. Protein structure prediction
43. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase
44. Design of selective and soluble inhibitors of tumor necrosis factor alpha converting enzyme (TACE)
45. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands
46. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity
47. Docking ligands onto binding site representations derived from proteins built by homology modelling
48. Comparative protein structure modeling of genes and genomes
49. Development of a virtual screening method for identification of 'frequent hitters' in compound libraries
50. Reactive compounds and in vitro false positives in HTS
51. Simple selection criteria for drug-like chemical matter
52. Improving the odds in discriminating 'drug-like' from 'non drug-like' compounds
53. Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM
54. General topological patterns of known drugs
55. Drug-like index: A new approach to measure drug-like compounds and their diversity
56. Property distribution of drug-related chemical databases
57. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
58. Discovery of a new inhibitor lead of adenovirus proteinase: Steps toward selective, irreversible inhibitors of cysteine proteinases
59. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi